Infectious complications in patients undergoing unrelated donor bone marrow transplantation: Experience from a single institution

Clinical Microbiology and Infection

Volumn 8, Issue 11, 2002, Pages 725-733

  Saaverda, S ^a   Jarque, I ^a   Sanz, G F ^a   Moscardo, F ^a   Jimenez C ^a   Martin G ^a   Plume, G ^a   Regadera, A ^a   Martinez J ^a   De la Rubia, J ^a   Acosta, B ^a   Peman J ^a   Perez Belles C ^a   Gobernado, M ^a   Sanz, M A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bone marrow transplantation; Infection; Unrelated donor

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BUSULFAN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; GANCICLOVIR; GLYCOPEPTIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOGLOBULINE; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; NYSTATIN; PIPERACILLIN; PREDNISONE; TAZOBACTAM; TEICOPLANIN; THIOTEPA; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VANCOMYCIN; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; BACTEREMIA; BACTERIAL INFECTION; CAUSE OF DEATH; CITROBACTER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG MEGADOSE; EXPERIENCE; FEVER; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTIOUS COMPLICATION; LIVING DONOR; MEDICAL DOCUMENTATION; MORTALITY; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SEPSIS; TIME; TOXOPLASMOSIS; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); CITROBACTER; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; NEGIBACTERIA;

EID: 18744390006     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00458.x     Document Type: Article

References (46)

1. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of haematologic malignancies. Transplantation 1991; 51: 443-7.
2. Goldman JM, Schmitz N, Niethammer D, Gratwohl A. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Bone Marrow Transplant 1998; 21: 1-7.
3. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
4. Ringden O, Remberger M, Runde V et al. Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation. Bone Marrow Transplant 2000; 26(suppl 2): S6-8.
5. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.
6. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994; 18: 273-84.
7. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first two years. Ann Intern Med 1993; 119: 207-14.
8. Ochs L, Shu XO, Miller J et al. Late infections after allogeneic bone marrow transplantations, comparison of the incidence in related and unrelated donor transplant recipients. Blood 1995; 86: 3976-86.
9. Takenaka K, Gondo H, Tanimoto K et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic transplantation from unrelated donors. Bone Marrow Transplant 1997; 19: 241-87.
10. Williamson E, Millar M, Steward C et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560-8.
11. Terasaki PI, McLelland J. Microdroplet assay of human serum cytoxins. Nature 1964; 204: 988-1000.
12. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
13. Buyse I, Decorte R, Cuppens H et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993; 41: 1-14.
14. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-304.
15. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-8.
16. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study in 20 Seattle patients. Am J Med 1980; 69: 204-17.
17. Emanuel D, Cunningham I, Jules EK et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777-82.
18. Pizzo PA, Armstrong D, Bodey G et al. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of consensus panel. J Infect Dis 1990; 161: 397-401.
19. Rubin M, Harthorn JW, Marshall D et al. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988; 108: 30-5.
20. Hughes W, Armstrong D, Bodey G et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25: 551-73.
21. Ljungman P, Griffiths P. Definitions of CMV infection and disease. Excerpta Medica Int Congress Ser 1993; 1032: 233-7.
22. Ljungman P. Infections in blood and marrow transplantation. In: Apperley JF, Gluckman E, Gratwohl A, eds. The EBMT Handbook. Paris, France: European School of Heamatology, 2000; 164-81.
23. Engels EA, Ellis CA, Supran SE et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999; 28: 256-66.
24. Hoyle C, Goldman JM. Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 1994; 14: 247-52.
25. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478-88.
26. Miller W, Flynn P, McCullogh J et al. Cytomegalovirus infection after bone marrow transplantation, and association with acute graft-v-host disease. Blood 1986; 67: 1162-7.
27. Przepiorka D, Ippoliti C, Panina J et al. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplant 1994; 13: 461-4.
28. Boeckh M, Riddell S, Cunningham T, Myerson D, Flowers M, Bowden R. Increased risk of late CMV infection and disease in allogeneic marrow transplant after ganciclovir prophylaxis is due to lack of CMV-specific T cell responses. Blood 1996; 88(Suppl. 1): 302a.
29. Ljungman P, Lambertenghi G, Platzbecker U et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. Blood 2001; 97: 388-92.
30. Martino R, Martinez C, Pericas R et al. Bacteraemia due to glucose non-fermenting gram-negative bacilli in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 1996; 15: 610-15.
31. Quinn JP. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 1998; 27: 117-24.
32. Cisneros SM, Reyes MJ, Pachón J et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996; 22: 1026-32.
33. Arns de Cunha C, Weisdorf D, Sho XO, DeFor T, Pastor JD, Johnson JR. Early gram-positive bacteremia in BMT recipients, impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21: 173-80.
34. Ribaud P, Chastang C, Latgé JP et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28: 322-30.
35. Einsele H, Hebart H, Roller G et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353-60.
36. Maertens J, Verhaegen J, Lagrou K et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-10.
37. Whimbey E, Champlin R, Englund J et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 393-9.
38. Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 1989; 4: 35-40.
39. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102(suppl 3A): 44-7.
40. Chang J, Powles R, Mehta J, Paton N, Treleaven J, Jameson B. Listeriosis in bone marrow transplant recipients: incidence, clinical features and treatment. Clin Infect Dis 1995; 21: 1289-90.
41. Martino R, López R, Pericas R, Badell I, Sureda A, Brunet S. Listeriosis in bone marrow transplant recipients. Clin Infect Dis 1996; 23: 419-20.
42. Bhave AA, Thirunavukkasaru K, Gottlied DJ et al. Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD. Bone Marrow Transplant 1999; 23: 519-21.
43. van Burik JA, Hackman RC, Nadeem SQ et al. Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis 1997; 24: 1154-60.
44. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and review of the literature. Bone Marrow Transplant 1997; 19: 685-9.
45. Derouin F, Devergie A, Auber P et al. Toxoplasmosis in bone marrow transplant recipients; report of seven cases and review. Clin Infect Dis 1992; 15: 267-70.
46. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant patients: a 20-year experience. Bone Marrow Transplant 1994; 13: 549-57.